Cite
Resolving therapy resistance mechanisms in multiple myeloma by multiomics subclone analysis.
MLA
Poos, Alexandra M., et al. “Resolving Therapy Resistance Mechanisms in Multiple Myeloma by Multiomics Subclone Analysis.” Blood, vol. 142, no. 19, Nov. 2023, pp. 1633–46. EBSCOhost, https://doi.org/10.1182/blood.2023019758.
APA
Poos, A. M., Prokoph, N., Przybilla, M. J., Mallm, J.-P., Steiger, S., Seufert, I., John, L., Tirier, S. M., Bauer, K., Baumann, A., Rohleder, J., Munawar, U., Rasche, L., Kortüm, K. M., Giesen, N., Reichert, P., Huhn, S., Müller-Tidow, C., Goldschmidt, H., … Weinhold, N. (2023). Resolving therapy resistance mechanisms in multiple myeloma by multiomics subclone analysis. Blood, 142(19), 1633–1646. https://doi.org/10.1182/blood.2023019758
Chicago
Poos, Alexandra M, Nina Prokoph, Moritz J Przybilla, Jan-Philipp Mallm, Simon Steiger, Isabelle Seufert, Lukas John, et al. 2023. “Resolving Therapy Resistance Mechanisms in Multiple Myeloma by Multiomics Subclone Analysis.” Blood 142 (19): 1633–46. doi:10.1182/blood.2023019758.